Literature DB >> 9467531

Clinical review 92: Phytoestrogens.

A L Murkies1, G Wilcox, S R Davis.   

Abstract

We have reviewed the literature regarding the food sources, potency, population intakes, and known biological effects of phytoestrogens in humans using MEDLINE data base from the years 1975-1996. Over 600 articles pertinent to the metabolism of phytoestrogens, including female reproduction (in particular menstruation and menopause), cardiovascular disease, osteoporosis, and cancer were assessed including relevant case control or cohort studies, as well as randomized trials and review articles. Epidemiological studies regarding human data were included, as well as human cell line and animal studies when there were no relevant human data available. We conclude that phytoestrogens exhibit physiological effects in humans. Mild estrogenic changes occur in postmenopausal women. Benefits are seen regarding hypercholesterolaemia. Epidemiological, animal, and in vitro data encourage further assessment of the role of phytoestrogens in cancer prevention.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467531     DOI: 10.1210/jcem.83.2.4577

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  64 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan Okey; Patricia Harper
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

3.  Cross-cultural comparison of women's midlife symptom-reporting: a China study.

Authors:  Jeanne L Shea
Journal:  Cult Med Psychiatry       Date:  2006-09

4.  Use of phytoestrogens in menopause.

Authors:  G Scambia; D Gallo; E Foti
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

Review 5.  Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

Authors:  Rodney Baber; Martha Hickey; Michelle Kwik
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense).

Authors:  Cassia R Overk; Ping Yao; Lucas R Chadwick; Dejan Nikolic; Yongkai Sun; Muriel A Cuendet; Yunfan Deng; A S Hedayat; Guido F Pauli; Norman R Farnsworth; Richard B van Breemen; Judy L Bolton
Journal:  J Agric Food Chem       Date:  2005-08-10       Impact factor: 5.279

7.  Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.

Authors:  Wai-Sum Lau; Wen-Fang Chen; Robbie Yat-Kan Chan; De-An Guo; Man-Sau Wong
Journal:  Br J Pharmacol       Date:  2009-03-09       Impact factor: 8.739

8.  Bone regeneration potential of a soybean-based filler: experimental study in a rabbit cancellous bone defects.

Authors:  Gianluca Giavaresi; Milena Fini; Jonathan Salvage; Nicolò Nicoli Aldini; Roberto Giardino; Luigi Ambrosio; Luigi Nicolais; Matteo Santin
Journal:  J Mater Sci Mater Med       Date:  2009-09-22       Impact factor: 3.896

Review 9.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

10.  Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.

Authors:  Cornelia Charles; Julia Yuskavage; Olga Carlson; Majnu John; Arlene S Tagalicud; Marcello Maggio; Denis C Muller; Josephine Egan; Shehzad Basaria
Journal:  Menopause       Date:  2009 Mar-Apr       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.